The announcement of a class action lawsuit against Novo Nordisk A/S is likely to have a negative short-term impact on its stock price as it introduces legal uncertainty and potential financial liabilities. Shareholders seeking recovery for losses may indicate dissatisfaction with the company's performance or disclosures, which can further pressure the stock.